{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Diarylsulfonylurea_Compound_ILX-295501",
  "nciThesaurus": {
    "casRegistry": "150869-74-2",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "ILX-295501 is a novel sulfonylurea compound that has demonstrated in-vivo antitumor activity against a broad spectrum of solid tumors.",
    "fdaUniiCode": "240Y4YO0TN",
    "identifier": "C1632",
    "preferredName": "Diarylsulfonylurea Compound ILX-295501",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C2186"
    ],
    "synonyms": [
      "Diarylsulfonylurea Compound ILX-295501",
      "ILX 295501",
      "ILX-295501",
      "ILX295501",
      "LY 295501",
      "LY-295501",
      "LY295501",
      "N-(((3,4-Dichlorophenyl)amino)carbonyl)-2,3-dihydro-5-benzofuransulfonamide",
      "N-(5-(2,3-Dihydrobenzofuryl)sulfonyl)-N'-(3,4-dichlorophenyl)urea"
    ]
  }
}